Your Sorted CME/CE Activities

Independent Conference Coverage from The American Thoracic Society (ATS) International Conference 2022*
AMA/ANCC/ACPE Activity - Clinical Clips
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in San Francisco, California, May 13-18, 2022 through a series of two ‘What You Need to Know in 5-minutes’ videos.
Claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of each brief Post-Test/Evaluation.

Aaron Waxman, MD, PhD, FACP, FCCP Aaron Waxman, MD, PhD, FACP, FCCP
Director, Pulmonary Vascular Disease Program
Executive Director, Center for Pulmonary-Heart Diseases
Brigham and Women’s Hospital Heart and Vascular Center
Associate Professor of Medicine
Harvard Medical School
Steven Nathan, MD Steven Nathan, MD
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of The American Thoracic Society (ATS) International Conference 2022.
Supported by independent educational grants from United Therapeutics, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson

Launch Date: May 16, 2022
Release Date: May 16, 2022
Expiration Date: April 30, 2023

April 30, 2023
Mini Module